Influenza Vaccine Market Revenue was valued at USD 6.45 Billion in 2024 and is estimated to reach USD 11.23 Billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033.
The global Influenza Vaccine Market was valued at approximately USD 4.2 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. The increasing awareness regarding the need for seasonal flu prevention, coupled with government initiatives for vaccination programs, has significantly contributed to the market growth. With the ongoing development of advanced influenza vaccines, there is an increasing preference for vaccines offering broader protection against multiple strains. Moreover, the rising geriatric population, who are at higher risk of influenza, is expected to further boost market growth in the coming years.
Regionally, North America held the largest market share in 2022, accounting for around 40% of the global influenza vaccine market. The region's high vaccination rate and robust healthcare infrastructure have been key drivers. Europe follows closely, with the market expected to grow at a CAGR of 6.5% during the forecast period. Asia-Pacific is anticipated to witness the fastest growth, driven by rising healthcare access and awareness in emerging economies like China and India. The Middle East & Africa and Latin America are also expected to contribute significantly to market expansion, owing to increasing public health initiatives and rising vaccination uptake.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=112809&utm_source=Google site_G_April&utm_medium=235
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
Folia Biotech
Genentech
Green Cross
Medicago
Moderna Therapeutics
Novavax
Shijiazhuang Yiling Pharmaceutical
SK Chemicals
UNM Pharma
Vaccitec
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=112809&utm_source=Google site_G_April&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Influenza Vaccine Market
Live Attenuated Influenza Vaccine (LAIV)
Inactivated Influenza Vaccine (IIV)
Recombinant Influenza Vaccine (RIV)
Quadrivalent Influenza Vaccine
Trivalent Influenza Vaccine
Intramuscular Injection
Intranasal Administration
Subcutaneous Injection
Intradermal Administration
Pediatrics (6 months to 17 years)
Adults (18 to 64 years)
Elderly (65 years and above)
Hospitals
Clinics
Pharmacies
Vaccination Centers
Home Care Settings
Pre-filled Syringes
Vials
Nasally Administered Sprays
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/influenza-vaccine-market/
1. Introduction of the Global Influenza Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Influenza Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Influenza Vaccine Market, By Type
6. Global Influenza Vaccine Market, By Application
7. Global Influenza Vaccine Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Influenza Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/